PharmaTutor Magazine - February 2017 is released | Subscribe today
No legal action taken on ADR reporter, clarified by IPC
Some ADR reporters may be have phobia that they may be detained or baited by law but Indian Pharmacopoiea commission (IPC) informed that there will be no legal action taken on Adverse drug reaction (ADR) reporter. And active participation in ADR reporting is needed from all healthcare professionals, as IPC concern.
The Pharmacovigilance and Adverse Drug Reaction (ADR) reporting among the healthcare professionals needs to be scaled up. It can be done by developing educational and promotional interventions like continuous medical education, awareness programme, workshops, conferences on pharmacovigilance, etc.
IPC said in a notification that "Pharmacovigilance is based on sound scientific principles and is an integral part of effective clinical practices. The discipline need to develop further to meet the demands of public health for which continuous monitoring of drugs is essentials. Such monitoring will help in assessing, monitoring and detecting adverse effects of drugs, their interactions etc. that can result in higher morbidity and mortality. The initiative will help to maximize benefits and minimize risks associated with drugs."
It is emphasized that reporting of adverse events shall not have any legal obligation on reporter, therefore your active participation in ADR reporting is need of the hour.
On behalf of editorial team, I sincerely thank all authors for sharing their views and research with us. Hope we will receive similar support in future also